Manufacturing, Mergers and Acquisitions, Research and Development
May 24, 2024
Via: Biopharm InternationalOn May 22, 2024, AGC Biologics and BioConnection, a contract manufacturing organization specializing in aseptic filling of vials and syringes for clinical and commercial production, announced that they have entered into a new strategic partnership. Under the agreement, the companies […]
February 7, 2023
Via: Contract PharmaGenenta Science, a clinical-stage biotechnology company engaged in the development of hematopoietic stem progenitor cell immuno-gene therapy for cancer, has entered into a development and manufacturing service agreement (MSA) with AGC Biologics S.p.A. to manufacture cell therapy lentivirus-based product for […]
Cell and Gene Therapy, Industry
July 28, 2022
Via: Contract PharmaAGC Biologics, a global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), entered a new partnership with Altheia Science, a gene therapy company pioneering cell and gene therapy strategies to treat autoimmune diseases and cancer. Under the alliance,Altheia Science aims to […]
Manufacturing, Research and Development
September 14, 2021
Via: Contract PharmaAGC Biologics, a global biopharmaceutical contract development and manufacturing organization (CDMO), unveiled expansion plans for the company’s Heidelberg facility to increase manufacturing capacities for plasmid-DNA (pDNA) and messenger RNA (mRNA) projects. With this expansion, AGC Biologics is boosting its current […]
July 19, 2024
July 11, 2024
July 11, 2024
Copyright © 2024. All rights reserved
